高リスク骨髄異形成症候群または慢性骨髄単球性白血病患者の治療におけるレナリドミドまたはボリノスタット併用または非併用のアザシチジン
高リスク骨髄異形成症候群(MDS)および慢性骨髄単球性白血病(CMML)を対象とした、レナリドマイドと組み合わせたアザシチジン(NSC-703813)vs.アザシチジン単独vs.ボリノスタット(NSC-701852)と組み合わせたアザシチジンの無作為化第II / III相試験
This randomized phase II/III trial studies how well azacitidine works with or without lenalidomide or vorinostat in treating patients with higher-risk myelodysplastic syndromes or chronic myelomonocytic leukemia. Drugs used in chemotherapy, such as azacitidine, work in different ways to stop the growth of cancer cells, either by killing the cells, stopping them from dividing, or by stopping them from spreading. Lenalidomide may stop the growth of cancer cells by stopping blood flow to the cancer. Vorinostat may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. It is not yet known whether azacitidine is more effective with or without lenalidomide or vorinostat in treating myelodysplastic syndromes or chronic myelomonocytic leukemia.
調査の概要
状態
状態
条件
条件
介入・治療
介入・治療
詳細な説明
PRIMARY OBJECTIVES:
I. To select based on response rate (complete remission, partial remission, or hematologic improvement) either the combination of lenalidomide and azacitidine or the combination of vorinostat and azacitidine for further testing against single-agent azacitidine among patients with higher-risk myelodysplastic syndromes (MDS) or chronic myelomonocytic leukemia (CMML). (Phase II) II. To compare overall survival between the combination arm selected in the Phase II portion of the trial to single-agent azacitidine among patients with higher-risk myelodysplastic syndromes (MDS) or chronic myelomonocytic leukemia (CMML). (Phase III)
SECONDARY OBJECTIVES:
I. To estimate relapse-free survival, overall survival and cytogenetic response rate of patients treated on each regimen.
II. To estimate the frequency and severity of toxicities of the three regimens in this patient population.
III. To investigate in a preliminary manner the frequency of subgroups from prestudy cytogenetic studies and correlate these subgroups with clinical outcomes in this patient population.
IV. To collect specimens for banking for use in future research studies.
TERTIARY OBJECTIVES:
I. To evaluate the prevalence of a pre-specified list of molecular lesions (48 total lesions).
II. To assess associations of these lesions with outcomes (response, event-free survival, relapse-free survival, and overall survival).
III. To develop a deoxyribonucleic acid (DNA) methylation biomarker predictive of response to DMTi treatment in MDS.
IV. To harness gene expression profiles as clinical biomarkers of primary resistance to DMTi in MDS.
OUTLINE: Patients are randomized to 1 of 3 treatment arms. In Phase III, patients are randomized to 1 of 2 treatment arms (the combination arm selected in Phase II or the single-agent azacitidine arm).
ARM I: Patients receive azacitidine subcutaneously (SC) or intravenously (IV) on days 1-7 or days 1-5 and 8-9, and lenalidomide orally (PO) once daily (QD) on days 1-21.
ARM II: Patients receive azacitidine as in Arm I.
ARM III: Patients receive azacitidine as in Arm I and vorinostat PO twice daily (BID) on days 3-9.
In all arms, treatment repeats every 28 days for up to 5 years in the absence of disease progression or unacceptable toxicity.
After completion of study treatment, patients are followed up every 3 months for up to 5 years.
研究の種類
研究の種類
入学 (実際)
入学
段階
段階
- フェーズ2
連絡先と場所
研究場所
-
-
Alabama
-
Birmingham、Alabama、アメリカ、35233
- University of Alabama at Birmingham Cancer Center
-
Mobile、Alabama、アメリカ、36688
- University of South Alabama Mitchell Cancer Institute
-
-
Arizona
-
Scottsdale、Arizona、アメリカ、85259
- Mayo Clinic in Arizona
-
Tucson、Arizona、アメリカ、85719
- Banner University Medical Center - Tucson
-
Tucson、Arizona、アメリカ、85719
- University of Arizona Cancer Center-North Campus
-
-
Arkansas
-
Little Rock、Arkansas、アメリカ、72205
- John L McClellan Memorial Veterans Hospital
-
-
California
-
Antioch、California、アメリカ、94531
- Kaiser Permanente-Deer Valley Medical Center
-
Duarte、California、アメリカ、91010
- City of Hope Comprehensive Cancer Center
-
Los Angeles、California、アメリカ、90033
- USC / Norris Comprehensive Cancer Center
-
Oakland、California、アメリカ、94611
- Kaiser Permanente-Oakland
-
Palo Alto、California、アメリカ、94304
- Stanford Cancer Institute Palo Alto
-
Richmond、California、アメリカ、94801
- Kaiser Permanente-Richmond
-
Sacramento、California、アメリカ、95823
- Kaiser Permanente-South Sacramento
-
Sacramento、California、アメリカ、95825
- Kaiser Permanente Sacramento Medical Center
-
San Francisco、California、アメリカ、94115
- Kaiser Permanente-San Francisco
-
San Jose、California、アメリカ、95119
- Kaiser Permanente-Santa Teresa-San Jose
-
San Rafael、California、アメリカ、94903
- Kaiser Permanente-San Rafael
-
Santa Clara、California、アメリカ、95051
- Kaiser Permanente Medical Center - Santa Clara
-
Santa Rosa、California、アメリカ、95403
- Kaiser Permanente-Santa Rosa
-
Santa Rosa、California、アメリカ、95403
- Sutter Pacific Medical Foundation
-
South San Francisco、California、アメリカ、94080
- Kaiser Permanente-South San Francisco
-
Vallejo、California、アメリカ、94589
- Kaiser Permanente-Vallejo
-
Walnut Creek、California、アメリカ、94596
- Kaiser Permanente-Walnut Creek
-
-
Colorado
-
Aurora、Colorado、アメリカ、80012
- The Medical Center of Aurora
-
Aurora、Colorado、アメリカ、80045
- UCHealth University of Colorado Hospital
-
Boulder、Colorado、アメリカ、80303
- Boulder Community Foothills Hospital
-
Colorado Springs、Colorado、アメリカ、80907
- Penrose-Saint Francis Healthcare
-
Denver、Colorado、アメリカ、80218
- Presbyterian - Saint Lukes Medical Center - Health One
-
Denver、Colorado、アメリカ、80220
- Rose Medical Center
-
Denver、Colorado、アメリカ、80218
- Rocky Mountain Cancer Centers-Midtown
-
Denver、Colorado、アメリカ、80220
- Rocky Mountain Cancer Centers-Rose
-
Denver、Colorado、アメリカ、80218
- Colorado Blood Cancer Institute
-
Denver、Colorado、アメリカ、80222
- Western States Cancer Research NCORP
-
Denver、Colorado、アメリカ、80218
- Saint Joseph Hospital - Cancer Centers of Colorado
-
Denver、Colorado、アメリカ、80210
- AdventHealth Porter
-
Durango、Colorado、アメリカ、81301
- Mercy Medical Center
-
Englewood、Colorado、アメリカ、80113
- Mountain Blue Cancer Care Center - Swedish
-
Englewood、Colorado、アメリカ、80113
- Swedish Medical Center
-
Fort Collins、Colorado、アメリカ、80524
- Poudre Valley Hospital
-
Golden、Colorado、アメリカ、80401
- Mountain Blue Cancer Care Center
-
Greeley、Colorado、アメリカ、80631
- Banner North Colorado Medical Center
-
Greenwood Village、Colorado、アメリカ、80111
- Rocky Mountain Cancer Centers-Greenwood Village
-
Lakewood、Colorado、アメリカ、80228
- Rocky Mountain Cancer Centers-Lakewood
-
Lakewood、Colorado、アメリカ、80228
- CommonSpirit Saint Anthony Hospital Cancer Center
-
Littleton、Colorado、アメリカ、80122
- AdventHealth Littleton
-
Lone Tree、Colorado、アメリカ、80124
- Sky Ridge Medical Center
-
Lone Tree、Colorado、アメリカ、80124
- Rocky Mountain Cancer Centers-Sky Ridge
-
Longmont、Colorado、アメリカ、80501
- Longmont United Hospital
-
Loveland、Colorado、アメリカ、80539
- Banner North Colorado Medical Center - Loveland Campus
-
Parker、Colorado、アメリカ、80138
- Rocky Mountain Cancer Centers-Parker
-
Parker、Colorado、アメリカ、80138
- AdventHealth Parker
-
Pueblo、Colorado、アメリカ、81004
- Saint Mary Corwin Medical Center
-
Wheat Ridge、Colorado、アメリカ、80401
- Intermountain Health Lutheran Hospital
-
-
Connecticut
-
Farmington、Connecticut、アメリカ、06030
- University of Connecticut
-
Hartford、Connecticut、アメリカ、06105
- Smilow Cancer Hospital Care Center at Saint Francis
-
New Britain、Connecticut、アメリカ、06050
- The Hospital of Central Connecticut
-
-
Delaware
-
Lewes、Delaware、アメリカ、19958
- Beebe Medical Center
-
Newark、Delaware、アメリカ、19718
- Christiana Care Health System-Christiana Hospital
-
-
District of Columbia
-
Washington D.C.、District of Columbia、アメリカ、20016
- Sibley Memorial Hospital
-
Washington D.C.、District of Columbia、アメリカ、20422
- Veterans Affairs Medical Center -Washington DC
-
-
Florida
-
Gainesville、Florida、アメリカ、32610
- UF Health Cancer Institute - Gainesville
-
Jupiter、Florida、アメリカ、33458
- Jupiter Medical Center
-
Miami Beach、Florida、アメリカ、33140
- Mount Sinai Medical Center
-
Orlando、Florida、アメリカ、32803
- AdventHealth Orlando
-
-
Georgia
-
Augusta、Georgia、アメリカ、30912
- Augusta University Medical Center
-
-
Hawaii
-
Honolulu、Hawaii、アメリカ、96813
- Hawaii Cancer Care Inc - Waterfront Plaza
-
Honolulu、Hawaii、アメリカ、96813
- Straub Clinic and Hospital
-
Honolulu、Hawaii、アメリカ、96813
- University of Hawaii Cancer Center
-
Honolulu、Hawaii、アメリカ、96817
- Queen's Cancer Center - Kuakini
-
Honolulu、Hawaii、アメリカ、96819
- Kaiser Permanente Moanalua Medical Center
-
-
Idaho
-
Boise、Idaho、アメリカ、83706
- Saint Alphonsus Cancer Care Center-Boise
-
Post Falls、Idaho、アメリカ、83854
- Kootenai Clinic Cancer Services - Post Falls
-
-
Illinois
-
Bloomington、Illinois、アメリカ、61704
- Illinois CancerCare-Bloomington
-
Canton、Illinois、アメリカ、61520
- Illinois CancerCare-Canton
-
Carthage、Illinois、アメリカ、62321
- Illinois CancerCare-Carthage
-
Chicago、Illinois、アメリカ、60611
- Northwestern University
-
Chicago、Illinois、アメリカ、60637
- University of Chicago Comprehensive Cancer Center
-
Chicago、Illinois、アメリカ、60612
- University of Illinois
-
Chicago、Illinois、アメリカ、60611
- Hematology and Oncology Associates
-
Decatur、Illinois、アメリカ、62526
- Decatur Memorial Hospital
-
Decatur、Illinois、アメリカ、62526
- Heartland Cancer Research NCORP
-
Eureka、Illinois、アメリカ、61530
- Illinois CancerCare-Eureka
-
Evanston、Illinois、アメリカ、60201
- NorthShore University HealthSystem-Evanston Hospital
-
Galesburg、Illinois、アメリカ、61401
- Illinois CancerCare-Galesburg
-
Havana、Illinois、アメリカ、62644
- Illinois CancerCare-Havana
-
Kewanee、Illinois、アメリカ、61443
- Illinois CancerCare-Kewanee Clinic
-
Macomb、Illinois、アメリカ、61455
- Illinois CancerCare-Macomb
-
Maywood、Illinois、アメリカ、60153
- Loyola University Medical Center
-
Moline、Illinois、アメリカ、61265
- Trinity Medical Center
-
Monmouth、Illinois、アメリカ、61462
- Illinois CancerCare-Monmouth
-
Normal、Illinois、アメリカ、61761
- Illinois CancerCare-Community Cancer Center
-
Ottawa、Illinois、アメリカ、61350
- Illinois CancerCare-Ottawa Clinic
-
Pekin、Illinois、アメリカ、61554
- Illinois CancerCare-Pekin
-
Peoria、Illinois、アメリカ、61615
- Illinois CancerCare-Peoria
-
Peru、Illinois、アメリカ、61354
- Illinois CancerCare-Peru
-
Princeton、Illinois、アメリカ、61356
- Illinois CancerCare-Princeton
-
Rockford、Illinois、アメリカ、61104
- Swedish American Hospital
-
Rockford、Illinois、アメリカ、61114
- UW Health Carbone Cancer Center Rockford
-
Springfield、Illinois、アメリカ、62781
- Springfield Memorial Hospital
-
Urbana、Illinois、アメリカ、61801
- Carle Cancer Center
-
-
Indiana
-
Merrillville、Indiana、アメリカ、46410
- Premier Oncology Hematology Associates
-
-
Iowa
-
Ames、Iowa、アメリカ、50010
- McFarland Clinic - Ames
-
Iowa City、Iowa、アメリカ、52242
- University of Iowa/Holden Comprehensive Cancer Center
-
Sioux City、Iowa、アメリカ、51101
- Siouxland Regional Cancer Center
-
Waterloo、Iowa、アメリカ、50702
- MercyOne Waterloo Cancer Center
-
-
Kansas
-
Kansas City、Kansas、アメリカ、66160
- University of Kansas Cancer Center
-
Prairie Village、Kansas、アメリカ、66208
- Kansas City NCI Community Oncology Research Program
-
Topeka、Kansas、アメリカ、66606
- Cotton O'Neil Cancer Center / Stormont Vail Health
-
-
Kentucky
-
Lexington、Kentucky、アメリカ、40536
- University of Kentucky/Markey Cancer Center
-
-
Louisiana
-
Baton Rouge、Louisiana、アメリカ、70809
- Ochsner Health Center-Summa
-
New Orleans、Louisiana、アメリカ、70121
- Ochsner Medical Center Jefferson
-
Shreveport、Louisiana、アメリカ、71103
- LSU Health Sciences Center at Shreveport
-
-
Maine
-
Bangor、Maine、アメリカ、04401
- Eastern Maine Medical Center
-
-
Maryland
-
Baltimore、Maryland、アメリカ、21287
- Johns Hopkins University/Sidney Kimmel Cancer Center
-
Elkton、Maryland、アメリカ、21921
- Christiana Care - Union Hospital
-
-
Massachusetts
-
Boston、Massachusetts、アメリカ、02215
- Dana-Farber Cancer Institute
-
Boston、Massachusetts、アメリカ、02114
- Massachusetts General Hospital Cancer Center
-
Brighton、Massachusetts、アメリカ、02135
- Dana-Farber Cancer Institute at Boston Medical Center - Brighton
-
Springfield、Massachusetts、アメリカ、01199
- Baystate Medical Center
-
Worcester、Massachusetts、アメリカ、01655
- UMass Memorial Medical Center - University Campus
-
-
Michigan
-
Ann Arbor、Michigan、アメリカ、48106
- Michigan Cancer Research Consortium NCORP
-
Ann Arbor、Michigan、アメリカ、48106
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor
-
Battle Creek、Michigan、アメリカ、49017
- Bronson Battle Creek
-
Detroit、Michigan、アメリカ、48201
- Wayne State University/Karmanos Cancer Institute
-
Detroit、Michigan、アメリカ、48236
- Henry Ford Health Saint John Hospital
-
Escanaba、Michigan、アメリカ、49829
- OSF Saint Francis Hospital and Medical Group
-
Grand Rapids、Michigan、アメリカ、49503
- Cancer Research Consortium of West Michigan NCORP
-
Grand Rapids、Michigan、アメリカ、49503
- Trinity Health Grand Rapids Hospital
-
Grand Rapids、Michigan、アメリカ、49503
- Corewell Health Grand Rapids Hospitals - Butterworth Hospital
-
Kalamazoo、Michigan、アメリカ、49007
- West Michigan Cancer Center
-
Muskegon、Michigan、アメリカ、49444
- Trinity Health Muskegon Hospital
-
Port Huron、Michigan、アメリカ、48060
- Lake Huron Medical Center
-
Reed City、Michigan、アメリカ、49677
- Corewell Health Reed City Hospital
-
Traverse City、Michigan、アメリカ、49684
- Munson Medical Center
-
Warren、Michigan、アメリカ、48093
- Henry Ford Health Warren Hospital
-
-
Minnesota
-
Bemidji、Minnesota、アメリカ、56601
- Sanford Joe Lueken Cancer Center
-
Burnsville、Minnesota、アメリカ、55337
- Fairview Ridges Hospital
-
Coon Rapids、Minnesota、アメリカ、55433
- Mercy Hospital
-
Duluth、Minnesota、アメリカ、55805
- Essentia Health Cancer Center
-
Edina、Minnesota、アメリカ、55435
- Fairview Southdale Hospital
-
Fridley、Minnesota、アメリカ、55432
- Unity Hospital
-
Hutchinson、Minnesota、アメリカ、55350
- Hutchinson Area Health Care
-
Maplewood、Minnesota、アメリカ、55109
- Saint John's Hospital - Healtheast
-
Maplewood、Minnesota、アメリカ、55109
- Minnesota Oncology Hematology PA-Maplewood
-
Minneapolis、Minnesota、アメリカ、55415
- Hennepin County Medical Center
-
Minneapolis、Minnesota、アメリカ、55407
- Abbott-Northwestern Hospital
-
Minneapolis、Minnesota、アメリカ、55417
- Minneapolis VA Medical Center
-
Robbinsdale、Minnesota、アメリカ、55422
- North Memorial Medical Health Center
-
Rochester、Minnesota、アメリカ、55905
- Mayo Clinic in Rochester
-
Saint Cloud、Minnesota、アメリカ、56303
- Coborn Cancer Center at Saint Cloud Hospital
-
Saint Louis Park、Minnesota、アメリカ、55416
- Park Nicollet Clinic - Saint Louis Park
-
Saint Louis Park、Minnesota、アメリカ、55416
- Metro Minnesota Community Oncology Research Consortium
-
Saint Paul、Minnesota、アメリカ、55101
- Regions Hospital
-
Saint Paul、Minnesota、アメリカ、55102
- United Hospital
-
Shakopee、Minnesota、アメリカ、55379
- Saint Francis Regional Medical Center
-
Stillwater、Minnesota、アメリカ、55082
- Lakeview Hospital
-
Waconia、Minnesota、アメリカ、55387
- Ridgeview Medical Center
-
Willmar、Minnesota、アメリカ、56201
- Rice Memorial Hospital
-
Woodbury、Minnesota、アメリカ、55125
- Minnesota Oncology Hematology PA-Woodbury
-
-
Mississippi
-
Jackson、Mississippi、アメリカ、39216
- University of Mississippi Medical Center
-
-
Missouri
-
Cape Girardeau、Missouri、アメリカ、63703
- Saint Francis Medical Center
-
Columbia、Missouri、アメリカ、65201
- Veterans Administration
-
Columbia、Missouri、アメリカ、65212
- MU Health - University Hospital/Ellis Fischel Cancer Center
-
Kansas City、Missouri、アメリカ、64111
- Saint Luke's Hospital of Kansas City
-
St Louis、Missouri、アメリカ、63141
- Mercy Hospital Saint Louis
-
St Louis、Missouri、アメリカ、63141
- Saint Louis-Cape Girardeau CCOP
-
-
Montana
-
Billings、Montana、アメリカ、59101
- Billings Clinic Cancer Center
-
Bozeman、Montana、アメリカ、59715
- Bozeman Health Deaconess Hospital
-
-
New Jersey
-
Camden、New Jersey、アメリカ、08103
- Cooper Hospital University Medical Center
-
-
New Mexico
-
Albuquerque、New Mexico、アメリカ、87106
- University of New Mexico Cancer Center
-
Albuquerque、New Mexico、アメリカ、87110
- Presbyterian Kaseman Hospital
-
-
New York
-
Buffalo、New York、アメリカ、14263
- Roswell Park Cancer Institute
-
Lake Success、New York、アメリカ、11042
- Northwell Health/Center for Advanced Medicine
-
Manhasset、New York、アメリカ、11030
- North Shore University Hospital
-
Mineola、New York、アメリカ、11501
- NYU Langone Hospital - Long Island
-
New York、New York、アメリカ、10065
- NYP/Weill Cornell Medical Center
-
Rochester、New York、アメリカ、14642
- University of Rochester
-
The Bronx、New York、アメリカ、10467
- Montefiore Medical Center - Moses Campus
-
The Bronx、New York、アメリカ、10461
- Montefiore Medical Center-Weiler Hospital
-
-
North Carolina
-
Asheboro、North Carolina、アメリカ、27203
- Randolph Hospital
-
Goldsboro、North Carolina、アメリカ、27534
- Wayne Memorial Hospital
-
Greensboro、North Carolina、アメリカ、27403
- Cone Health Cancer Center
-
Hendersonville、North Carolina、アメリカ、28791
- Margaret R Pardee Memorial Hospital
-
Kinston、North Carolina、アメリカ、28501
- ECU Health Oncology Kinston
-
Pinehurst、North Carolina、アメリカ、28374
- FirstHealth of the Carolinas-Moore Regional Hospital
-
Reidsville、North Carolina、アメリカ、27320
- Annie Penn Memorial Hospital
-
Statesville、North Carolina、アメリカ、28677
- Iredell Memorial Hospital
-
Winston-Salem、North Carolina、アメリカ、27104
- Southeast Clinical Oncology Research Consortium NCORP
-
-
North Dakota
-
Bismarck、North Dakota、アメリカ、58501
- Sanford Bismarck Medical Center
-
Bismarck、North Dakota、アメリカ、58501
- Mid Dakota Clinic
-
Fargo、North Dakota、アメリカ、58122
- Sanford Roger Maris Cancer Center
-
Fargo、North Dakota、アメリカ、58122
- Sanford Broadway Medical Center
-
-
Ohio
-
Beachwood、Ohio、アメリカ、44122
- Cleveland Clinic Cancer Center Beachwood
-
Cincinnati、Ohio、アメリカ、45219
- University of Cincinnati Cancer Center-UC Medical Center
-
Cleveland、Ohio、アメリカ、44106
- Case Western Reserve University
-
Cleveland、Ohio、アメリカ、44195
- Cleveland Clinic Foundation
-
Cleveland、Ohio、アメリカ、44111
- Cleveland Clinic Cancer Center/Fairview Hospital
-
Columbus、Ohio、アメリカ、43214
- Riverside Methodist Hospital
-
Columbus、Ohio、アメリカ、43219
- The Mark H Zangmeister Center
-
Columbus、Ohio、アメリカ、43222
- Mount Carmel Health Center West
-
Columbus、Ohio、アメリカ、43215
- Columbus NCI Community Oncology Research Program
-
Dayton、Ohio、アメリカ、45409
- Miami Valley Hospital
-
Independence、Ohio、アメリカ、44131
- Cleveland Clinic Cancer Center Independence
-
Marietta、Ohio、アメリカ、45750
- Marietta Memorial Hospital
-
Mayfield Heights、Ohio、アメリカ、44124
- Hillcrest Hospital Cancer Center
-
Newark、Ohio、アメリカ、43055
- Licking Memorial Hospital
-
Parma、Ohio、アメリカ、44129
- University Hospitals Parma Medical Center
-
Sandusky、Ohio、アメリカ、44870
- North Coast Cancer Care
-
Springfield、Ohio、アメリカ、45504
- Springfield Regional Medical Center
-
Strongsville、Ohio、アメリカ、44136
- Cleveland Clinic Cancer Center Strongsville
-
Sylvania、Ohio、アメリカ、43560
- ProMedica Flower Hospital
-
Toledo、Ohio、アメリカ、43614
- University of Toledo
-
Westerville、Ohio、アメリカ、43081
- Saint Ann's Hospital
-
Wooster、Ohio、アメリカ、44691
- Cleveland Clinic Wooster Family Health and Surgery Center
-
-
Oklahoma
-
Norman、Oklahoma、アメリカ、73071
- Cancer Care Associates-Norman
-
Oklahoma City、Oklahoma、アメリカ、73104
- University of Oklahoma Health Sciences Center
-
Oklahoma City、Oklahoma、アメリカ、73120
- Mercy Hospital Oklahoma City
-
-
Oregon
-
Gresham、Oregon、アメリカ、97030
- Legacy Mount Hood Medical Center
-
Milwaukie、Oregon、アメリカ、97222
- Providence Milwaukie Hospital
-
Newberg、Oregon、アメリカ、97132
- Providence Newberg Medical Center
-
Oregon City、Oregon、アメリカ、97045
- Providence Willamette Falls Medical Center
-
Portland、Oregon、アメリカ、97210
- Legacy Good Samaritan Hospital and Medical Center
-
Portland、Oregon、アメリカ、97213
- Providence Portland Medical Center
-
Portland、Oregon、アメリカ、97225
- Providence Saint Vincent Medical Center
-
-
Pennsylvania
-
Allentown、Pennsylvania、アメリカ、18103
- Lehigh Valley Hospital-Cedar Crest
-
Carlisle、Pennsylvania、アメリカ、17015
- Carlisle Regional Cancer Center
-
Danville、Pennsylvania、アメリカ、17822
- Geisinger Medical Center
-
Doylestown、Pennsylvania、アメリカ、18901
- Doylestown Hospital
-
Hazleton、Pennsylvania、アメリカ、18201
- Geisinger Medical Center-Cancer Center Hazleton
-
Hershey、Pennsylvania、アメリカ、17033-0850
- Penn State Milton S Hershey Medical Center
-
Pittsburgh、Pennsylvania、アメリカ、15232
- UPMC Hillman Cancer Center
-
Sayre、Pennsylvania、アメリカ、18840
- Guthrie Medical Group PC-Robert Packer Hospital
-
West Reading、Pennsylvania、アメリカ、19611
- Reading Hospital
-
Wilkes-Barre、Pennsylvania、アメリカ、18711
- Geisinger Wyoming Valley/Henry Cancer Center
-
-
South Carolina
-
Boiling Springs、South Carolina、アメリカ、29316
- Prisma Health Cancer Institute - Spartanburg
-
Charleston、South Carolina、アメリカ、29401
- Roper Hospital
-
Greenville、South Carolina、アメリカ、29605
- Prisma Health Cancer Institute - Faris
-
Greenville、South Carolina、アメリカ、29615
- Prisma Health Cancer Institute - Eastside
-
Greenville、South Carolina、アメリカ、29605
- Prisma Health Cancer Institute - Butternut
-
Greenville、South Carolina、アメリカ、29601
- Saint Francis Hospital
-
Greenville、South Carolina、アメリカ、29605
- Prisma Health Greenville Memorial Hospital
-
Seneca、South Carolina、アメリカ、29672
- Prisma Health Cancer Institute - Seneca
-
Spartanburg、South Carolina、アメリカ、29303
- Spartanburg Medical Center
-
-
South Dakota
-
Rapid City、South Dakota、アメリカ、57701
- Rapid City Regional Hospital
-
Sioux Falls、South Dakota、アメリカ、57117-5134
- Sanford USD Medical Center - Sioux Falls
-
Sioux Falls、South Dakota、アメリカ、57104
- Sanford Cancer Center Oncology Clinic
-
-
Tennessee
-
Knoxville、Tennessee、アメリカ、37916
- Covenant Health Cancer Centers
-
Nashville、Tennessee、アメリカ、37232
- Vanderbilt University/Ingram Cancer Center
-
-
Texas
-
Amarillo、Texas、アメリカ、79106
- The Don and Sybil Harrington Cancer Center
-
Dallas、Texas、アメリカ、75390
- UT Southwestern/Simmons Cancer Center-Dallas
-
-
Utah
-
Salt Lake City、Utah、アメリカ、84112
- Huntsman Cancer Institute/University of Utah
-
-
Virginia
-
Martinsville、Virginia、アメリカ、24112
- Sovah Health Martinsville
-
-
Washington
-
Vancouver、Washington、アメリカ、98664
- PeaceHealth Southwest Medical Center
-
-
West Virginia
-
Morgantown、West Virginia、アメリカ、26506
- West Virginia University Healthcare
-
-
Wisconsin
-
Chippewa Falls、Wisconsin、アメリカ、54729
- Marshfield Clinic-Chippewa Center
-
Eau Claire、Wisconsin、アメリカ、54701
- HSHS Sacred Heart Hospital
-
Eau Claire、Wisconsin、アメリカ、54701
- Marshfield Clinic Cancer Center at Sacred Heart
-
Green Bay、Wisconsin、アメリカ、54311
- Aurora BayCare Medical Center
-
Green Bay、Wisconsin、アメリカ、54301
- Saint Vincent Hospital Cancer Center Green Bay
-
Green Bay、Wisconsin、アメリカ、54303
- Saint Vincent Hospital Cancer Center at Saint Mary's
-
Green Bay、Wisconsin、アメリカ、54301-3526
- Green Bay Oncology at Saint Vincent Hospital
-
Janesville、Wisconsin、アメリカ、53548
- Mercyhealth Hospital and Cancer Center - Janesville
-
La Crosse、Wisconsin、アメリカ、54601
- Gundersen Lutheran Medical Center
-
Madison、Wisconsin、アメリカ、53715
- SSM Health Dean Medical Group - South Madison Campus
-
Marinette、Wisconsin、アメリカ、54143
- Aurora Bay Area Medical Group-Marinette
-
Marinette、Wisconsin、アメリカ、54143
- Bay Area Medical Center
-
Marshfield、Wisconsin、アメリカ、54449
- Marshfield Medical Center-Marshfield
-
Marshfield、Wisconsin、アメリカ、54449
- Marshfield Medical Center
-
Milwaukee、Wisconsin、アメリカ、53226
- Medical College of Wisconsin
-
Minocqua、Wisconsin、アメリカ、54548
- Marshfield Medical Center - Minocqua
-
Oconomowoc、Wisconsin、アメリカ、53066
- ProHealth Oconomowoc Memorial Hospital
-
Oconto Falls、Wisconsin、アメリカ、54154
- Saint Vincent Hospital Cancer Center at Oconto Falls
-
Rhinelander、Wisconsin、アメリカ、54501
- Aspirus Cancer Care-Rhinelander-James Beck Cancer Center
-
Rice Lake、Wisconsin、アメリカ、54868
- Marshfield Medical Center-Rice Lake
-
Stevens Point、Wisconsin、アメリカ、54481
- Aspirus Cancer Care - Stevens Point
-
Summit、Wisconsin、アメリカ、53066
- Aurora Medical Center in Summit
-
Waukesha、Wisconsin、アメリカ、53188
- ProHealth Waukesha Memorial Hospital
-
Wauwatosa、Wisconsin、アメリカ、53226
- Aurora Cancer Care-Milwaukee West
-
Weston、Wisconsin、アメリカ、54476
- Marshfield Medical Center - Weston
-
Wisconsin Rapids、Wisconsin、アメリカ、54494
- Marshfield Clinic - Wisconsin Rapids Center
-
-
-
-
Alberta
-
Calgary、Alberta、カナダ、T2N 5G2
- Arthur J E Child Comprehensive Cancer Centre
-
-
British Columbia
-
Vancouver、British Columbia、カナダ、V5Z 3P1
- Clinical Research Unit at Vancouver Coastal Health Authority
-
-
Manitoba
-
Winnipeg、Manitoba、カナダ、R3E 0V9
- CancerCare Manitoba
-
-
New Brunswick
-
Moncton、New Brunswick、カナダ、E1C 6Z8
- The Moncton Hospital
-
Saint John、New Brunswick、カナダ、E2L 4L2
- Atlantic Health Sciences Corporation-Saint John Regional Hospital
-
-
Nova Scotia
-
Halifax、Nova Scotia、カナダ、B3H 2Y9
- QEII Health Sciences Centre/Nova Scotia Health Authority
-
-
Ontario
-
Hamilton、Ontario、カナダ、L8V 5C2
- Juravinski Cancer Centre at Hamilton Health Sciences
-
Toronto、Ontario、カナダ、M5G 2M9
- University Health Network-Princess Margaret Hospital
-
Toronto、Ontario、カナダ、M4N 3M5
- Odette Cancer Centre- Sunnybrook Health Sciences Centre
-
-
Quebec
-
Greenfield Park、Quebec、カナダ、J4V 2H1
- CSSS Champlain-Charles Le Moyne
-
Montreal、Quebec、カナダ、H3H 2R9
- The Research Institute of the McGill University Health Centre (MUHC)
-
Montreal、Quebec、カナダ、H2W 1S6
- McGill University Department of Oncology
-
-
Saskatchewan
-
Regina、Saskatchewan、カナダ、S4T 7T1
- Allan Blair Cancer Centre
-
Saskatoon、Saskatchewan、カナダ、S7N 4H4
- Saskatoon Cancer Centre
-
-
参加基準
適格基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
-
Patients must have morphologically confirmed diagnosis of myelodysplastic syndrome (MDS) or chronic myelomonocytic leukemia (CMML) based on one of the following:
-
French-American-British (FAB) classifications:
- Refractory anemia with excess blasts (RAEB - defined as having 5-20% myeloblasts in the bone marrow)
- Chronic myelomonocytic leukemia (CMML) with 10-19% myeloblasts in the bone marrow and/or 5-19% blasts in the blood
-
World Health Organization (WHO) classifications:
- Refractory anemia with excess blasts-1 (RAEB-1 - defined as having 5-9% myeloblasts in the bone marrow)
- Refractory anemia with excess blasts-2 (RAEB-2 - defined as having 10-19% myeloblasts in the bone marrow and/or 5-19% blasts in the blood)
- Chronic myelomonocytic leukemia-1 (CMML-1 - defined as having < 10% myeloblasts in the bone marrow and/or < 5% blasts in the blood)
- Chronic myelomonocytic leukemia-2 (CMML-2 - defined as having 10-19% myeloblasts in the bone marrow and/or 5-19% blasts in the blood) OR
-
International prognostic score (IPSS) of intermediate 2 (1.5-2.0 points) or high (>= 2.5 points); a score of intermediate 1 (0.5-1.0 points) is only allowable in the setting of >= 5% myeloblasts
-
NOTE: Patients with acute myeloid leukemia (AML) are not eligible
-
Procedures to obtain specimens for establishing baseline disease must be done within 30 days prior to registration
-
-
Patients must not have received lenalidomide, azacitidine, vorinostat, or decitabine as treatment previously; any hematopoietic growth factors must be stopped for at least 14 days prior to registration; patients may have received low-dose cytarabine for MDS treatment previously, but they must have discontinued its use for at least 28 days prior to registration; patients may have received prior hydroxyurea per CMML treatment previously, but they must have discontinued its use for at least 7 days prior to registration; these patients will not be eligible if white blood cell (WBC) > 30,000/mm^3
-
Patients must not have received radiation therapy, chemotherapy, or cytotoxic therapy to treat conditions other than MDS within 12 months prior to registration
-
Patients must not have undergone prior allogeneic stem cell or bone marrow transplantation at any time; patients that have undergone an autologous stem cell transplant are eligible
-
Patients must not have used or be using histone deacetylase (HDAC) inhibitor agents for anticancer treatment
-
Patients may not have received agents such as valproic acid for epilepsy within 30 days prior to registration
-
Patients must have Zubrod performance status of 0-2
-
Patients must not have any pre-existing neurotoxicity/neuropathy of >= grade 2 according to the National Cancer Institute (NCI) Common Toxicity Criteria version 4.0, or prior >= grade 3 allergic reaction/hypersensitivity or rash to thalidomide, that has not resolved to < grade 2
-
Patients must not have any serious medical condition, laboratory abnormality, or psychiatric illness that, in the view of the treating physician, would place the participant at an unacceptable risk if he or she were to participate in the study or would prevent that person from giving informed consent
-
Patients must not have history of thromboembolic event or other condition requiring current use of anticoagulation with Coumadin (warfarin) or low molecular-weight heparin
-
Patients must not have known or suspected hypersensitivity to mannitol
-
Patients must receive a 12-lead electrocardiogram (EKG), chest x-ray or computed tomography (CT) scan, serum creatinine, complete metabolic panel including serum glutamic oxaloacetic transaminase (SGOT) or serum glutamate pyruvate transaminase (SGPT), electrolytes, and bilirubin testing within 28 days prior to registration in order to establish baseline measurements; questions regarding patient safety in regards to results of these tests should be directed to the study chair
-
Females of childbearing potential (FCBP) must have a negative serum or urine pregnancy test with a sensitivity of at least 25 mIU/mL within 10 - 14 days prior to registration; FCBP must agree to have a second pregnancy test within 24 hours prior to starting cycle 1 if randomized to receive lenalidomide
- Further, patients commit to the following if they are randomized to receive lenalidomide: FCBP must either commit to continued abstinence from heterosexual intercourse or begin TWO acceptable methods of birth control: one highly effective method and one additional effective method AT THE SAME TIME, at least 28 days before starting lenalidomide; FCBP must also agree to ongoing pregnancy testing; men must agree to use a latex condom during sexual contact with a FCBP, even if they have had a successful vasectomy; a FCBP is a sexually mature woman who: 1) has not undergone a hysterectomy or bilateral oophorectomy; or 2) has not been naturally postmenopausal for at least 24 consecutive months (i.e., has had menses at any time in the preceding 24 consecutive months); all patients must be counseled by a trained counselor every 28 days about pregnancy precautions and risks of fetal exposure
- NOTE: Patients not randomized to receive lenalidomide will not be required to undergo serial pregnancy testing or lenalidomide counseling after registration
-
No prior malignancy is allowed except for adequately treated basal cell (or squamous cell) skin cancer, in situ cervical cancer, or other cancer for which the patient has been disease-free for three years
-
Cytogenetics requirements:
- Southwestern Oncology Group (SWOG) (and other sites not affiliated with Alliance or Eastern Cooperative Oncology Group [ECOG]-American College of Radiology Imaging Network [ACRIN]): Pretreatment cytogenetics must be performed on all patients; collection of pretreatment specimens must be completed within 30 days prior to registration to S1117; specimens must be submitted to the site's preferred Clinical Laboratory Improvement Amendments (CLIA)-approved cytogenetics laboratory; reports of the results must be submitted as described; note that cytogenetics are required at other timepoints; NOTE: National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) sites may submit specimens to College of American Pathologists (CAP) or Ontario Laboratory Accreditation (OLA)-approved laboratories providing the lab is licensed to perform fluorescent in situ hybridization (FISH) analysis
- Alliance: Alliance patients must enroll on Cancer and Leukemia Group B (CALGB) 8461, the cytogenetics protocol; CALGB 8461 provides sample procurement and submission instructions to Alliance-approved institutional cytogeneticists; note that cytogenetics are required at other timepoints
- ECOG-ACRIN: Pretreatment cytogenetics must be performed on all patients; collection of pretreatment specimens must be completed within 30 days prior to registration to S1117; specimens must be submitted to the site's preferred CLIA-approved cytogenetics laboratory; karyotypes and reports must be submitted for review to the Mayo Clinic Cytogenetics Laboratory in Rochester; note that cytogenetics testing is required at other timepoints
-
Banking requirements:
- SWOG, Alliance and ECOG-ACRIN (and other sites not affiliated with NCIC CTG): Patients must be offered participation in specimen banking; with patient consent, specimens must be submitted as outlined
- Alliance: (Temporarily Closed 2/28/14): As of February 28, 2014, CALGB 9665 has been temporarily closed, so Alliance patients under consideration for S1117 are NOT to be registered to CALGB 9665 and no specimens for patients enrolled after February 28, 2014 are to be submitted via this ancillary study; these patients should submit specimens per SWOG instructions; patients already enrolled on CALGB 9665 should continue to submit specimens per instructions in CALGB 9665
- NCIC CTG: NCIC CTG patients must be offered participation in specimen submission and banking; with patient consent, specimens must be submitted as outlined
-
All patients or their legally authorized representative must be informed of the investigational nature of this study and must sign and give written informed consent in accordance with institutional and federal guidelines
-
As a part of the Oncology Patient Enrollment Network (OPEN) registration process the treating institution's identity is provided in order to ensure that the current (within 365 days) date of institutional review board approval for this study has been entered in the system
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:処理
- 割り当て:ランダム化
- 介入モデル:並列代入
- マスキング:なし(オープンラベル)
アーム数
武器と介入
参加者グループ / アーム参加者グループ / アーム |
介入・治療介入・治療 |
|---|---|
|
実験的:Arm I (azacitidine and lenalidomide)
Patients receive azacitidine SC or IV on days 1-7 or days 1-5 and 8-9, and lenalidomide PO QD on days 1-21. Courses repeat every 28 days for up to 5 years in the absence of disease progression or unacceptable toxicity. |
Correlative studies Given PO
他の名前:
Given SC or IV
他の名前:
|
|
実験的:Arm II (azacitidine)
Patients receive azacitidine as in Arm I. Courses repeat every 28 days for up to 5 years in the absence of disease progression or unacceptable toxicity. |
Correlative studies Given SC or IV
他の名前:
|
|
実験的:Arm III (azacitidine and vorinostat)
Patients receive azacitidine as in Arm I and vorinostat PO BID on days 3-9. Courses repeat every 28 days for up to 5 years in the absence of disease progression or unacceptable toxicity. |
Correlative studies Given SC or IV
他の名前:
Given PO
他の名前:
|
この研究は何を測定していますか?
主要な結果の測定
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Response Rate (Phase II)
時間枠:Up to 5 years
|
A response is any of complete hematological remission, partial remission, or hematologic improvement. |
Up to 5 years
|
|
Overall Survival (Phase III)
時間枠:Up to 5 years
|
OS is calculated for all patients from the date of initial registration to date of death due to any cause. The follow-up for patients last known to be alive is censored at the date of last contact. Stratified Cox regression models will be used to compare OS of the combination arm selected in the Phase II portion of the trial to OS of the single-agent azacitidine arm. |
Up to 5 years
|
二次結果の測定
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Relapse-free Survival
時間枠:Up to 5 years
|
RFS is calculated for patients who have achieved a response. RFS will be measured from the date of response to the date of first documentation of relapse from response (as defined in the primary objective), or death due to any cause. The follow-up for patients last known to be alive and without report of relapse is censored at the date of last contact. RFS will be estimated for each of the three arms using the Kaplan-Meier method. |
Up to 5 years
|
|
Overall Survival
時間枠:Up to 5 years
|
OS is calculated for all patients from the date of initial registration to date of death due to any cause. The follow- up for patients last known to be alive is censored at the date of last contact. OS will be estimated for each of the three arms using the Kaplan-Meier method. |
Up to 5 years
|
|
Pre-study Cytogenetic Abnormalities
時間枠:Up to 5 years
|
Cytogenetic risk group is used to identify cytogenetic abnormalities. |
Up to 5 years
|
|
Toxicity Rate
時間枠:Up to 5 years
|
Adverse events that are possibly, probably or definitely related to study drug are reported. |
Up to 5 years
|
協力者と研究者
捜査官
捜査官
- 主任研究者:Mikkael A Sekeres、SWOG Cancer Research Network
出版物と役立つリンク
研究記録日
主要日程の研究
研究開始 (実際)
研究開始
一次修了 (実際)
一次修了
研究の完了 (推定)
研究の完了
試験登録日
最初に提出
最初に提出
QC基準を満たした最初の提出物
QC基準を満たした最初の提出物
最初の投稿 (推定)
最初の投稿
学習記録の更新
投稿された最後の更新 (実際)
投稿された最後の更新
QC基準を満たした最後の更新が送信されました
QC基準を満たした最後の更新が送信されました
最終確認日
最終確認日
詳しくは
本研究に関する用語
追加の関連 MeSH 用語
- 病理学的プロセス
- 新生物
- 慢性疾患
- 疾患の属性
- 遺伝性疾患、先天性疾患
- 組織型別の新生物
- 血液疾患
- 白血病、骨髄性
- 骨髄異形成 - 骨髄増殖性疾患
- 骨髄疾患
- 貧血
- 白血病
- 貧血、難治性
- 先天性、遺伝性、および新生児の疾患と異常
- 病理学的状態、徴候および症状
- ヘミックおよびリンパ疾患
- GATA2欠損症
- 白血病、骨髄単球性、慢性
- 骨髄異形成症候群
- 貧血、難治性、芽球過剰
- 有機化学物質
- 複素環化化合物、1リング
- 複素環化化合物
- 複素環化化合物、2リング
- 複素環化化合物、融合リング
- 核酸、ヌクレオチド、およびヌクレオシド
- カルボン酸
- ヒドロキシ酸
- アニリド
- アミド
- アニリン化合物
- アミン
- ピペリジン
- シチジン
- ピリミジンヌクレオシド
- ピリミジン
- AZA化合物
- ヌクレオシド
- リボヌクレオシド
- フタリミド
- フタル酸
- 酸、炭素環
- ピペリドン
- イソインドール
- ヒドロキサミン酸
- ヒドロキシルアミン
- レナリドミド
- ボリノスタット
- アザシチジン
その他の研究ID番号
その他の研究ID番号
- NCI-2012-00242
- U10CA032102 (米国 NIH グラント/契約)
- U10CA180888 (米国 NIH グラント/契約)
- NCI-2012-00242 (レジストリ識別子:CTRP (Clinical Trial Reporting Program))
- CDR0000723909
- SWOG-S1117
- S1117 (その他の識別子:CTEP)
- S1117 (その他の識別子:SWOG)
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。